logo

For the Inventor, By the Inventor

Ashiya, Japan

Yutaka Kuwada

USPTO Granted Patents = 18

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • Hyogo, JA (1976 - 1977)
  • Ashiya, JA (1976 - 1978)
  • Hyogo, JP (1978)
  • Ashiya, JP (1979 - 1984)

Company Filing History:

goldMedal18 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1976-1984

Loading Chart...
18 patents (USPTO):Explore Patents
1. 4463172 - Process for producing 2-methyl cephem-2-em and 2-methylcephem-3-em (1984-07-31),
2. 4235775 - Triazolobenzodiazepine derivatives (1980-11-25),
3. 4175079 - Benzodiazepine derivatives (1979-11-20),
4. 4150139 - Triazolobenzazepine derivatives (1979-04-17),
5. 4145418 - Thienopyridine substituted cephalosporins (1979-03-20),
6. 4116956 - Benzodiazepine derivatives (1978-09-26),
7. 4102881 - Benzodiazepine derivatives (1978-07-25),
8. 4082764 - Methods for the production of 4H-s-triazolo[4,3-a][1,4]benzodiazepine (1978-04-04),
9. 4079060 - Thienopyridine-carboxylic acid derivatives (1978-03-14),
10. 4049812 - Benzodiazepine carboxamides and pharmaceutical compositions with central (1977-09-20),
11. 4046772 - Benzodiazepine derivative and process for producing the same (1977-09-06),
12. 4044129 - 4-Pyridine carbonyl phenyl 1,2,4 triazoles (1977-08-23),
13. 4017620 - Thienodiazepine derivatives (1977-04-12),
14. 4013763 - Heterocyclic compounds (1977-03-22),
15. 4002638 - Benzazepine derivatives (1977-01-11),

Title: Yutaka Kuwada: Innovator in Pharmaceutical Chemistry

Introduction

Yutaka Kuwada is a prominent inventor based in Ashiya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel antibacterial agents and sedative compounds. With a total of 18 patents to his name, Kuwada's work has had a substantial impact on medical science.

Latest Patents

Kuwada's latest patents include a process for producing 2-methyl cephem-2-em and 2-methylcephem-3-em, which are novel 2-methylcephalosporin derivatives. These derivatives exhibit excellent antibacterial activities against both gram-positive and gram-negative bacteria, making them valuable as prophylactic or therapeutic agents for infections in humans and animals. Another notable patent involves triazolobenzodiazepine derivatives, specifically 1-aminomethyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine compounds. These compounds are useful as sedatives, tranquilizers, anticonvulsants, or hypnotics, along with processes for their production.

Career Highlights

Kuwada is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to focus on innovative research and development in the field of medicinal chemistry. His contributions have been recognized within the industry, and he continues to push the boundaries of pharmaceutical innovation.

Collaborations

Kuwada has collaborated with notable colleagues such as Kanji Meguro and Hiroyuki Tawada. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Yutaka Kuwada's innovative work in pharmaceutical chemistry has led to the development of important antibacterial and sedative compounds. His contributions continue to influence the field and improve therapeutic options for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…